State Street Corporation 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-20 08:55 am Sale |
2022-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
571,936 0.310% |
-11,171,525 (-95.13%) |
Filing |
| 2022-02-10 1:23 pm Sale |
2021-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
11,743,461 6.710% |
-2,263,176 (-16.16%) |
Filing |
| 2021-07-12 10:45 am Sale |
2021-06-30 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
14,006,637 8.750% |
-8,469,897 (-37.68%) |
Filing |
| 2021-02-11 12:43 pm Sale |
2020-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
22,476,534 15.550% |
-340,636 (-1.49%) |
Filing |
| 2021-02-10 10:26 am Purchase |
2021-01-31 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
22,817,170 15.790% |
7,476,699 (+48.74%) |
Filing |
| 2020-10-13 2:44 pm Purchase |
2020-09-30 | 13G | Akebia Therapeutics, Inc. AKBA |
STATE STREET CORP STT |
15,340,471 10.700% |
15,340,471 (New Position) |
Filing |